Germany· DE-A57-c3d453a9420f0b8a
Granocyte
A lenograstim product containing lenograstim, registered in Germany by Chugai Pharma Germany Gmbh. The same ATC class is registered in 8 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Lenograstim is registered in 8 of 19 countries.
Countries holding a registration under ATC L03AA10 (lenograstim), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 5 of them publish a price we can compare per daily dose
Lenograstim · ATC L03AA10
8 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Lenograstim
- Manufacturer
- Chugai Pharma Germany Gmbh
- Country
- Germany (DE)
- ATC code
- L03AA10
- ATC class
- Lenograstim
- Defined daily dose
- 0.35 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lenograstim in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceGRANOCYTE 13 Millions UI/ml, poudre et solvant pour solution injectable/perfusion en seringue préremplieCHUGAI PHARMA FRANCE
- United KingdomGranocyte 13million unit powder and solvent for solution for injection pre-filled syringesChugai Pharma UK Ltd
- Japanレノグラスチム（遺伝子組換え）中外製薬
- FinlandGranocyteSanofi Oy
- BelgiumGranocyte 13 1 10*6 IU/mlChugai Pharma France
- SpainGRANOCYTE 13 MILLONES DE UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE O PERFUSIONItalfarmaco S.A.
- IrelandGRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringeChugai Pharma France
- SwedenGranocyte 34 miljoner IE/ml Pulver och vätska till injektions-/infusionsvätska, lösningSanofi AB
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Granocyte
- France · Granocyte
- United Kingdom (Northern Ireland) · Granocyte
- Ireland · Granocyte
- Luxembourg · Granocyte
- Sweden · Granocyte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ecfcd17c-5b01-4f3c-a977-b4f0947caffb GET /v1/drugs/ecfcd17c-5b01-4f3c-a977-b4f0947caffb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use, Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Lenograstim",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about lenograstim.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.